Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

PHASE3TerminatedINTERVENTIONAL
Timeline

Start Date

January 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Lung Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

paclitaxel poliglumex

DRUG

vinorelbine tartrate

Trial Locations (10)

29403

Charleston Hematology-Oncology, P.A., Charleston

33065

Northwest Oncology and Hematology Associates, Coral Springs

35233

Cooper Green Hospital, Birmingham

58501

Clinical Research Services, Bismarck

60077

Midwest Cancer Research Group, Incorporated, Skokie

89502

Medschool Associates North, Reno

95020

Medical Oncology/Hematology, Gilroy

98201

Western Washington Medical Group, Everett

98502

Western Washington Oncology, Incorporated, Olympia

12110-0610

New York Oncology Hematology, P.C. - Latham, Latham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CTI BioPharma

INDUSTRY